Autocrine motility factor receptor is involved in the process of learning and memory in the central nervous system

Behavioural Brain Research

Volumn 229, Issue 2, 2012, Pages 412-418

  Yang, Yong ^a,b   Cheng, Xiao Rui ^a   Zhang, Gui Rong ^a   Zhou, Wen Xia ^a   Zhang, Yong Xiang ^a  

^a BEIJING INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (China)

^b SHANDONG UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Autocrine motility factor (AMF); Autocrine motility factor receptor (AMFR); Hippocampus; Learning and memory

Indexed keywords

AUTOCRINE MOTILITY FACTOR RECEPTOR; MESSENGER RNA; NOOTROPIC AGENT; SYNAPTOPHYSIN;

ANIMAL EXPERIMENT; ARTICLE; CELL ADHESION; CENTRAL NERVOUS SYSTEM; CHINESE MEDICINE; CONTROLLED STUDY; HIPPOCAMPUS; LEARNING; MALE; MEMORY; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENESCENCE ACCELERATED MOUSE; SYNAPTIC TRANSMISSION; UPREGULATION;

AGING; ALZHEIMER DISEASE; ANIMALS; ANIMALS, OUTBRED STRAINS; AVOIDANCE LEARNING; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; GENE EXPRESSION REGULATION; GLUCOSE-6-PHOSPHATE ISOMERASE; HIPPOCAMPUS; LEARNING; MALE; MEMORY; MICE; MOTOR ACTIVITY; NOOTROPIC AGENTS; RECEPTORS, AUTOCRINE MOTILITY FACTOR; SYNAPTOPHYSIN;

EID: 84862816265     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2012.01.043     Document Type: Article

References (49)

1. Chiu C.G., St-Pierre P., Nabi I.R., Wiseman S.M. Autocrine motility factor receptor: a clinical review. Expert Rev Anticancer Ther 2008, 8:207-217.
2. Luo Y., Long J.M., Lu C., Chan S.L., Spangler E.L., Mascarucci P., et al. A link between maze learning and hippocampal expression of neuroleukin and its receptor gp78. J Neurochem 2002, 80:354-361.
3. Alicja L., Edward M., Spangler L., Ingram D.K. Behavioral assessment of the senescence accelerated mouse (SAM P8 and R1). Physiol Behav 1998, 64:15-26.
4. Miyamoto M., Kiyota Y., Yamazaki N., Nagaoka A., Matsuo T., Nagawa Y., et al. Age-related changes in learning and memory in the senescence-accelerated mouse (SAM). Physiol Behav 1986, 38:399-406.
5. Miyamoto M. Characteristics of age-related behavioral changes in senescence-accelerated mouse SAMP8 and SAMP 10. Exp Gerontol 1997, 32:139-148.
6. Flood J.E., Morley J.E. Age-related changes in foot shock avoidance acquisition and retention in senescence accelerated mouse (SAM). Neurobiol Aging 1993, 14:153-157.
7. Ohta A., Hirano T., Yagi H., Tanaka S., Hosokawa M., Takeda T. Behavioral characteristics of the SAM-P/8 strain in Sidman active avoidance task. Brain Res 1989, 498:195-198.
8. Butterfield D.A., Poon H.F. The senescence-accelerated prone mouse (SAMP8): a model of age-related cognitive decline with relevance to alterations of the gene expression and protein abnormalities in Alzheimer's disease. Exp Gerontol 2005, 40:774-783.
9. Morley J.E. The SAMP8 mouse: a model of Alzheimer disease. Biogerontology 2002, 3:57-60.
10. Morley J.E., Banks W.A., Kumar V.B., Farr S.A. The SAMP8 mouse as a model for Alzheimer disease: studies from Saint Louis University. Int. Congress Series 2004, 1260:23-28.
11. Takeda T., Hosokawa M., Takeshita S., Rino M., Higuchi K., Matsushita T., et al. A new murine model of accelerated senescence. Mech Ageing Dev 1981, 17:183-194.
12. Cheng X.R., Zhou W.X., Zhang Y.X., Zhou D.S., Yang R.F., Chen L.F. Differential gene expression profiles in the hippocampus of senescence-accelerated mouse. Neurobiol Aging 2007, 28:497-506.
13. Cheng X.R., Zhou W.X., Zhang Y.X. The effects of Liuwei Dihuang decoction on the gene expression in the hippocampus of senescence-accelerated mouse. Fitoterapia 2007, 78:175-181.
14. Zheng Y., Cheng X.R., Zhou W.X., Zhang Y.X. Gene expression patterns of hippocampus and cerebral cortex of senescence-accelerated mouse treated with Huang-Lian-Jie-Du decoction. Neurosci Lett 2008, 439:119-124.
15. Zhang G.R., Cheng X.R., Zhou W.X., Zhang Y.X. Age-related expression of STUB1 in senescence-accelerated mice and its response to anti-Alzheimer's disease traditional Chinese medicine. Neurosci Lett 2008, 438:371-375.
16. Zhang G.R., Cheng X.R., Zhou W.X., Zhang Y.X. Age-related expression of calcium/calmodulin-dependent protein kinase II A in the hippocampus and cerebral cortex of senescence accelerated mouse prone/8 mice is modulated by anti-Alzheimer's disease drugs. Neuroscience 2009, 159:308-315.
17. Cheng X.R., Yang Y., Zhou W.X., Zhang Y.X. Expression of VGLUTs contributes to degeneration and acquisition of learning and memory. Neurobiol Learn Mem 2011, 95:361-375.
18. Yang S., Zhou W., Zhang Y., Yan C., Zhao Y. Effects of Liuwei Dihuang decoction on ion channels and synaptic transmission in cultured hippocampal neuron of rat. J Ethnopharmacol 2006, 106:166-172.
19. Hu Z.Y., Liu G., Yuan H., Yang S., Zhou W.X., Zhang Y.X., et al. Danggui-Shaoyao-San and its active fraction JD-30 improve Abeta-induced spatial recognition deficits in mice. J Ethnopharmacol 2010, 128:365-372.
20. Hu Z.Y., Liu G., Cheng X.R., Huang Y., Yang S., Qiao S.Y., et al. JD-30, an active fraction extracted from Danggui-Shaoyao-San, decreases β-amyloid content and deposition, improves LTP reduction and prevents spatial cognition impairment in SAMP8 mice. Exp Gerontol 2012, 47:14-22.
21. Qiao H.F., Yang S., Zhou W.X., Zhang Y.X. NT-1, an active constituent extracted from Tiaoxin Recipe, enhances long-term potentiation of CA1 subfield in rat hippocampal slices. Life Sci 2006, 79:8-15.
22. Kashani A., Lepicard E., Poirel O., Videau C., David J.P., Fallet-Bianco C., et al. Loss of VGLUT1 and VGLUT2 in the prefrontal cortex is correlated with cognitive decline in Alzheimer disease. Neurobiol Aging 2008, 29:1619-1630.
23. Tsutsumi S., Yanagawa T., Shimura T., Fukumori T., Hogan V., Kuwano H., et al. Regulation of cell proliferation by autocrine motility factor/phosphoglucose isomerase signaling. J Biol Chem 2003, 278:32165-32172.
24. Kugler W., Breme K., Laspe P., Muirhead H., Davies C., Winkler H., et al. Molecular basis of neurological dysfunction coupled with haemolytic anaemia in human glucose-6-phosphate isomerase (GPI) deficiency. Hum Genet 1998, 103:450-454.
25. Leclerc N., Vallée A., Nabi I.R. Expression of the AMF/neuroleukin receptor in developing and adult brain cerebellum. J Neurosci Res 2000, 60:602-612.
26. Yagi H., Katoh S., Akiguchi I., Takeda T. Age-related deterioration of ability of acquisition in memory and learning in senescence accelerated mouse: SAM-P/8 as an animal model of disturbances in recent memory. Brain Res 1988, 474:86-93.
27. Del Valle J., Duran-Vilaregut J., Manich G., Casadesús G., Smith M.A., Camins A., et al. Early amyloid accumulation in the hippocampus of SAMP8 mice. J Alzheimers Dis 2010, 19:1303-1315.
28. Pallas M., Camins A., Smith M.A., Perry G., Lee H.G., Casadesus G. From aging to Alzheimer's disease: unveiling the switch with the senescence-accelerated mouse model (SAMP8). J Alzheimers Dis 2008, 15:615-624.
29. Canudas A.M., Gutierrez-Cuesta J., Rodríguez M.I., Acuña-Castroviejo D., Sureda F.X., Camins A., et al. Hyperphosphorylation of microtubule-associated protein tau in senescence-accelerated mouse (SAM). Mech Ageing Dev 2005, 126:1300-1304.
30. Tajes M., Gutierrez-Cuesta J., Folch J., Ferrer I., Caballero B., Smith M.A., et al. Lithium treatment decreases activities of tau kinases in a murine model of senescence. J Neuropathol Exp Neurol 2008, 67:612-623.
31. Wu C.R., Lin L.W., Wang W.H., Hsieh M.T. The ameliorating effects of LiuWei Dihuang Wang on cycloheximide-induced impairment of passive avoidance performance in rats. J Ethnopharmacol 2007, 113:79-84.
32. Kang M., Kim J.H., Cho C., Lee K.Y., Shin M., Hong M., et al. Effects of Yukmijihwang-tang derivatives (YMJd) on ibotenic acid-induced amnesia in the rat. Biol Pharm Bull 2006, 29:1431-1435.
33. Rho S., Kang M., Choi B., Sim D., Lee J., Lee E., et al. Effects of Yukmijihwang-tang derivatives (YMJd), a memory enhancing herbal extract, on the gene-expression profile in the rat hippocampus. Biol Pharm Bull 2005, 28:87-93.
34. Park E., Kang M., Oh J.W., Jung M., Park C., Cho C., et al. Yukmijihwang-tang derivatives enhance cognitive processing in normal young adults: a double-blinded, placebo-controlled trial. Am J Chin Med 2005, 33:107-115.
35. Hsieh M.T., Cheng S.J., Lin L.W., Wang W.H., Wu C.R. The ameliorating effects of acute and chronic administration of LiuWei DihuangWang on learning performance in rodents. Biol Pharm Bull 2003, 26:156-161.
36. Chen S.S., Wang D.C., Chen T.J., Yang S.L. Administration of Chinese herbal medicines facilitates the locomotor activity in dystrophin-deficient mice. Am J Chin Med 2001, 29:281-292.
37. Iwasaki K., Kobayashi S., Chimura Y., Taguchi M., Inoue K., Cho S., et al. A randomized, double-blind, placebo-controlled clinical trial of the Chinese herbal medicine Ba Wei Di Huang Wan in the treatment of dementia. J Am Geriatr Soc 2004, 52:1518-1521.
38. Ninomiya H., Kato S., Okuda H. Effects of Hachimi-Jio-Gan in aged rats. J Altern Complement Med 2001, 7:355-359.
39. Hirokawa S., Nose M., Ishige A., Amagaya S., Oyama T., Ogihara Y. Effect of Hachimi-Jio-Gan on scopolamine-induced memory impairment and on acetylcholine content in rat brain. J Ethnopharmacol 1996, 50:77-84.
40. Hirokawa S., Nose M., Ishige A., Amagaya S., Ogihara Y. Effect of hachimijiogan, an oriental herbal medicinal mixture, on experimental amnesia in mice. Biol Pharm Bull 1994, 17:1182-1186.
41. Yu C.J., Zheng M.F., Kuang C.X., Huang W.D., Yang Q. Oren-gedoku-to and its constituents with therapeutic potential in Alzheimer's disease inhibit indoleamine 2,3-dioxygenase activity in vitro. J Alzheimers Dis 2010, 22:257-266.
42. Xu J., Murakami Y., Matsumoto K., Tohda M., Watanabe H., Zhang S., et al. Protective effect of Oren-gedoku-to (Huang-Lian-Jie-Du-Tang) against impairment of learning and memory induced by transient cerebral ischemia in mice. J Ethnopharmacol 2000, 73:405-413.
43. Fujiwara M., Iwasaki K. Toki-Shakuyaku-San and Oren-Gedoku-To improve the disruption of spatial cognition induced by cerebral ischaemia and central cholinergic dysfunction in rats. Phytother Res 1993, 7:s60-s62.
44. Kitabayashi Y., Shibata K., Nakamae T., Narumoto J., Fukui K. Effect of traditional Japanese herbal medicine Toki-Shakuyaku-San for mild cognitive impairment: SPECT study. Psychiatry Clin Neurosci 2007, 61:447-448.
45. Kou J., Zhu D., Yan Y. Neuroprotective effects of the aqueous extract of the Chinese medicine Danggui-Shaoyao-San on aged mice. J Ethnopharmacol 2005, 97:313-318.
46. Pu F., Mishima K., Egashira N., Akiyoshi Y., Liu A.X., Sano K., et al. Post-ischemic treatment with Toki-Shakuyaku-San (Tang-Gui-Shao-Yao-San) prevents the impairment of spatial memory induced by repeated cerebral ischemia in rats. Am J Chin Med 2005, 33:475-489.
47. Hatip-Al-Khatib I., Egashira N., Mishima K., Iwasaki K., Iwasaki K., Kurauchi K., et al. Determination of the effectiveness of components of the herbal medicine Toki-Shakuyaku-San and fractions of Angelica acutiloba in improving the scopolamine-induced impairment of rat's spatial cognition in eight-armed radial maze test. J Pharmacol Sci 2004, 96:33-41.
48. Mizushima Y., Kan S., Yoshida S., Irie Y., Urata Y. Effect of Choto-san, a Kampo medicine, on impairment of passive avoidance performance in senescence accelerated mouse (SAM). Phytother Res 2003, 17:542-545.
49. Li Y.M., Zhang C.Y., Wang J., Lin S.M. The effects of heart-benefiting recipe on the intellects of Alzheimer's disease patients whose state of illness were middle and serious. Modern Rehabil 2000, 4:996-997.